Does hyperinsulinemia lower SHBG and increase adipose aromatase, shifting the androgen-to-estrogen balance?

Research indicates that hyperinsulinemia and insulin resistance play a central role in disrupting hormonal balance in men, primarily by reducing the availability of testosterone and increasing the production of estrogens through hepatic and adipose-mediated pathways.

Clinical effectiveness and metabolic findings

In men, insulin resistance is consistently linked to a reduction in serum sex hormone-binding globulin (SHBG). Large-scale data from the Framingham Heart Study and NHANES have identified lower SHBG as an independent predictor for the development of metabolic syndrome and type 2 diabetes.

• SHBG levels: In subjects with newly diagnosed type 2 diabetes, SHBG levels are significantly lower compared to non-insulin-resistant controls, serving as a reliable marker for insulin resistance.
• Hormonal Ratios: The state of insulin resistance promotes a decreased androgen-to-estrogen ratio. This shift is characterized by a disproportionate reduction in total testosterone relative to estradiol, a hallmark of metabolic dysfunction.

Mechanistic explanations

The disruption of the androgen-to-estrogen balance occurs through two synergistic biological mechanisms:

• Hepatic SHBG suppression: High insulin levels suppress the liver’s production of SHBG. Mechanistically, hyperinsulinemia promotes de novo lipogenesis, leading to the accumulation of palmitoyl-CoA. This reduces the activity of Hepatocyte Nuclear Factor 4α (HNF4α), the primary transcription factor required for the SHBG gene. Additionally, proinflammatory cytokines (like TNF-α) associated with insulin resistance further inhibit HNF4α via NF-κB pathways.
• Adipose Aromatase upregulation: Insulin directly stimulates the transcription of the CYP19A1 gene (aromatase) in adipocytes. Furthermore, insulin resistance triggers macrophage infiltration in adipose tissue, releasing IL-6 and TNF-α. These cytokines upregulate aromatase activity, which accelerates the conversion of free androgens into estrogens.

Clinical implications for men

For men, particularly those in the 50+ age bracket, these hormonal shifts create a self-reinforcing cycle. Lower SHBG and increased aromatase activity lead to higher local and systemic estrogen levels. While some estrogen is necessary for metabolic health, the resulting "estrogen dominance" is associated with increased visceral adiposity, which in turn exacerbates insulin resistance and further suppresses testosterone production.

Bottom line

Hyperinsulinemia and insulin resistance significantly shift the hormonal balance toward estrogen by suppressing hepatic SHBG production and upregulating aromatase expression in adipose tissue. This decrease in the androgen-to-estrogen ratio is a key driver of metabolic and hormonal dysfunction in men.